斯坦丁相关的肌肉症状:识别和管理的建议
Kevin C Maki1,2, Carol F Kirkpatrick3,4, Mary Katherine Cheeley5
1Midwest Biomedical Research, 211 East Lake St., Ste. 3, Addison, IL, 60101, USA. kmaki@mbclinicalresearch.com.
Current atherosclerosis reports
|November 18, 2024
概括
类他类药物相关的肌肉症状 (SAMS) 是常见的,但许多患者仍然可以从类他类药物治疗中受益. 管理策略和替代药物有助于实现胆固醇目标并降低心血管风险.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 类他类药物是高LDL胆固醇的主要治疗方法,通常耐受良好.
- 可以出现与他类药物相关的肌肉症状 (SAMS),导致不耐受.
- 专业协会为管理SAMS提供指导.
研究的目的:
- 审查识别和管理SAMS的建议.
- 讨论在SAMS患者中管理异构脂蛋白的策略.
- 概述了尽管SAMS,但实现治疗目标的方法.
主要方法:
- 专业社会指导方针的文献综述.
- 对SAMS患病率和导致因素的分析.
- 对于他类药物不耐受症的管理策略的综合.
主要成果:
- SAMS是他类药物不耐受的最常见原因.
- 许多患者可以耐受修改后的他类药物治疗方案.
- 非他类药物提供了替代或辅助的选择.
结论:
- 对SAMS的有效管理对于坚持和降低心血管风险至关重要.
- 临床医生和患者之间的共同决策是关键.
- 在大多数SAMS患者中,可以实现治疗性脂质目标.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
538
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
538
Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Skeletal Muscle Relaxants: Adverse Effects
337
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
337
Myasthenia Gravis: Diagnostic Tests
655
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
655


